Search Results - "Habal, M.V."

VA ECMO as a Bridge to Transplantation: Emergent Eligibility and Outcomes by Habal, M.V, Garan, A.R, Topkara, V.K, Takeda, K, Latif, F, Restaino, S, Yuzefpolskaya, M, Bijou, R, Colombo, P, Takayama, H, Naka, Y, Farr, M

Get full text

821 Association of Heart Rate at Hospital Discharge With All-Cause Mortality in Patients With Heart Failure by Habal, M.V, Liu, P.P, Austin, P.C, Ross, H.J, Newton, G.E, Wang, X, Tu, J.V, Lee, D.S

Get full text

Managing Contemporary AMR with a 4-Tiered Treatment Protocol: A Single-Center Experience by Choe, J., Habal, M.V., Restaino, S.W., Latif, F., Clerkin, K.J., Yuzefpolskaya, M., Sayer, G., Uriel, N., Jennings, D.L.

“…Much remains unknown about the optimal diagnosis and treatment of antibody-mediated rejection (AMR) after heart transplant (HT). With limited literature…”
Get full text

Improvement in Coronary Allograft Vasculopathy Following Treatment with a Regimen Including Extracorporeal Photophoresis in a Heart Transplant Recipient by DeFilippis, E.M., Clerkin, K.J., Latif, F., Raikelkar, J.K., Topkara, V.K., Einstein, A., Sayer, G.T., Uriel, N., Weisberg, S.P., Habal, M.V., Restaino, S.W.

“…Extracorporeal photophoresis (ECP) has been used for select heart transplant (HT) recipients with acute cellular rejection, recurrent or refractory rejection,…”
Get full text

Effect of Mycophenolate Mofetil Dosing on 6-month Risk of Acute Cellular Rejection, Leukopenia and CMV Viremia in Heart Transplant by Braghieri, L., Pinsino, A., Mondellini, G.M., Finnigan, K., Takeda, K., Naka, Y., Clerkin, K.J., Habal, M.V., Latif, F., Farr, M.A., Sayer, G.T., Uriel, N., Colombo, P.C., Yuzefpolskaya, M., Jennings, D.L.

“…Mycophenolate mofetil (MMF) is a cornerstone of heart transplant (HT) therapy. MMF dose is associated with leukopenia and infections (eg CMV). Despite…”
Get full text

Tacrolimus Time in Therapeutic Range is Associated with Cellular Rejection and Gut Dysbiosis Early after Heart Transplant by Bohn, B., Jennings, D.L., Braghieri, L., Mondellini, G.M., Pinsino, A., Finnigan, K., Takeda, K., Naka, Y., Habal, M.V., Latif, F., Farr, M.A., Sayer, G.T., Uriel, N., Colombo, P.C., Demmer, R.T., Yuzefpolskaya, M.

“…Tacrolimus (TAC) is a cornerstone therapy in heart transplant (HT). Few studies have associated TAC time in therapeutic range (TTR) and coefficient of…”
Get full text

Psychiatric Comorbidities in Pediatric HT Patients Transitioning to Adult Care by Donald, E.M., Oren, D., Jackson, R., Lee, H.Y., Clerkin, K.J., Maldonado, A., Portera, M., Habal, M.V., Rothkopf, A., Latif, F., Fried, J.A., Raikhelkar, J., Yuzefpolskaya, M., Colombo, P.C., Restaino, S.W., Lee, S., Topkara, V.K., Lytrivi, I.D., Richmond, M.E., Zuckerman, W.A., Uriel, N., Sayer, G.

“…The transition from pediatric to adult care occurs during a vulnerable time of emerging adulthood (between 18 and 25 years of age) for pediatric heart…”
Get full text

Clonal Composition and Single-Cell Characterization of T-Cell Infiltrates in Cardiac Allograft Vasculopathy by Habal, M.V., Myung, A., Rao, S., See, S., Shihab, R.R., Roy, P., Marboe, C., Restaino, S., Han, A.S., Givertz, M., Madsen, J.C., Addonizio, L.J., Farr, M., Zorn, E.

“…T-cells are implicated in the pathogenesis of cardiac allograft vasculopathy (CAV), yet their clonal composition and function are incompletely defined. We…”
Get full text

Serum Cystatin C versus Creatinine Based Assessment of Renal Function in Heart Transplant Patients by Pinsino, A., Jennings, D.L., Mahoney, I., Sweat, A., Kim, A., Mondellini, G.M., Farhana, L., Restaino, S.W., Habal, M.V., Farr, M., Faillace, R.T., Takeda, K., Naka, Y., Demmer, R., Radhakrishnan, J., Colombo, P.C., Yuzefpolskaya, M.

“…Serum creatinine (sCr) is routinely used in the assessment of renal function among heart transplant (HT) pts. However, changes in muscle mass and nutritional…”
Get full text

Association of Plasma Trimethylamine-N-oxide and Serum Endothelin-1 with Cardiac Allograft Vasculopathy in Heart Transplant Recipients by Hupf, J.C., Onat, D., Javaid, A., Mondellini, G.M., Braghieri, L., Clerkin, K.J., Griffin, J.M., Latif, F., Restaino, S.W., Habal, M.V., Farr, M.A., Takeda, K., Naka, Y., Sayer, G.T., Uriel, N., Demmer, R.T., Colombo, P.C., Yuzefpolskaya, M.

“…Cardiac allograft vasculopathy (CAV) is a major complication that affects long-term survival after heart transplantation (HT). Multiple factors contribute to…”
Get full text